Market revenue in 2022 | USD 6.6 million |
Market revenue in 2030 | USD 10.9 million |
Growth rate | 6.4% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 39.39% in 2022. Horizon Databook has segmented the South Africa sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The sepsis diagnostics market in South Africa is primarily driven by the high prevalence of infectious diseases, such as HIV/AIDS and tuberculosis, which elevate the risk of sepsis. Increasing awareness of sepsis and its critical health impact also fuels market growth.
The South African market is predominantly characterized by laboratory-based tests, including blood cultures, microbiology assays, and serological tests, which typically require several hours to days for results.
However, there is a growing demand for point-of-care diagnostic tests, such as Procalcitonin (PCT) & C-Reactive Protein (CRP) tests, which offer rapid results and facilitate swift treatment decisions. This shift toward more immediate diagnostic solutions is expected to influence the market in the near future significantly.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account